Product Program year 2019 Source: CMS Open Payments

Ozanimod

Drug

Open in the dashboard

General payments

$1,980,051

2,265 payments

Research payments

$200,000

2 payments

Through program year 2019, $1,980,051 in general payments and $200,000 in research payments were reported against Ozanimod.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $1,980,051 2,265
2019 Research $200,000 2

Breakdown

Who paid General payments · program year 2019
  1. Celgene Corporation $1,980,051 2,265 payments
Top recipients General payments · program year 2019
  1. Thomas Leist Neurology · Philadelphia, PA $129,199 7% · 77 payments
  2. Barry Hendin Neurology · Phoenix, AZ $74,755 4% · 50 payments
  3. Bhupendra Khatri Neurology · Milwaukee, WI $56,857 3% · 36 payments
  4. David Hojnacki Neurology · Buffalo, NY $49,226 2% · 36 payments
  5. Steven Bromley Neurology · Audubon, NJ $48,539 2% · 22 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Neurology Psychiatry & Neurology $1,693,145 88% · 275 practitioners
  2. Gastroenterology Internal Medicine $119,998 6% · 61 practitioners
  3. Psychiatry Psychiatry & Neurology $23,376 1% · 2 practitioners
  4. Dermatology $16,453 <1% · 20 practitioners
  5. Clinical Neurophysiology Psychiatry & Neurology $14,111 <1% · 4 practitioners

The top 5 of 29 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Pennsylvania $203,230 10% · 24 recipients
  2. Texas $148,558 8% · 36 recipients
  3. New York $130,388 7% · 33 recipients
  4. Florida $121,429 6% · 37 recipients
  5. California $119,192 6% · 31 recipients

The top 5 of 48 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

2,265 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record